Hepatitis b virus impairs tlr9 expression and function in plasmacytoid dendritic cells

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Vincent, Isabelle E ^a,b   Zannetti, Claudia ^a,b,c   Lucifora, Julie ^d   Norder, Helene ^e   Protzer, Ulrike ^d   Hainaut, Pierre ^f   Zoulim, Fabien ^a,b,c   Tommasino, Massimo ^f   Trépo, Christian ^a,b,c   Hasan, Uzma ^a,b,c   Chemin, Isabelle ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GENOMIC DNA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; VIRUS DNA; TLR7 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PROTEIN SYNTHESIS INHIBITION; SENDAI VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRION; VIRUS ENTRY; VIRUS GENOME; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS TYPING; CELL CULTURE; DENDRITIC CELL; GENETICS; HEPATITIS B; IMMUNE EVASION; IMMUNOLOGY; LIVER TUMOR; PATHOGENICITY; VIROLOGY;

BACTERIA (MICROORGANISMS); HEPATITIS B VIRUS; SENDAI VIRUS;

B-LYMPHOCYTES; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; DENDRITIC CELLS; DOWN-REGULATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE EVASION; INTERFERON-ALPHA; LIVER NEOPLASMS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 80055026438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026315     Document Type: Article

References (45)

1. Lavanchy D, (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34 (Suppl 1): S1-3.
2. Lai CL, Ratziu V, Yuen MF, Poynard T, (2003) Viral hepatitis B. Lancet 362: 2089-2094.
3. Rehermann B, Nascimbeni M, (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.
4. Wieland SF, Chisari FV, (2005) Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79: 9369-9380.
5. Bertoletti A, Gehring AJ, (2006) The immune response during hepatitis B virus infection. J Gen Virol 87: 1439-1449.
6. Stetson DB, Medzhitov R, (2006) Type I interferons in host defense. Immunity 25: 373-381.
7. Medzhitov R, Janeway C Jr, (2000) The Toll receptor family and microbial recognition. Trends Microbiol 8: 452-456.
8. Li N, Fan XG, Chen ZH, Huang Y, Quan J, et al. (2005) Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B. Apmis 113: 647-654.
9. Barchet W, Cella M, Colonna M, (2005) Plasmacytoid dendritic cells--virus experts of innate immunity. Semin Immunol 17: 253-261.
10. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, et al. (2004) Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 24: 637-646.
11. Wang K, Fan X, Fan Y, Wang B, Han L, et al. (2007) Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection. J Viral Hepat 14: 276-282.
12. Ulsenheimer A, Gerlach JT, Jung MC, Gruener N, Wachtler M, et al. (2005) Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41: 643-651.
13. van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, et al. (2004) Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40: 738-746.
14. Beckebaum S, Cicinnati VR, Dworacki G, Muller-Berghaus J, Stolz D, et al. (2002) Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 104: 138-150.
15. van der Molen RG, Sprengers D, Biesta PJ, Kusters JG, Janssen HL, (2006) Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV. Hepatology 44: 907-914.
16. Xu Y, Hu Y, Shi B, Zhang X, Wang J, et al. (2009) HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 46: 2640-2646.
17. Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D, (2010) Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends Immunol 31: 391-397.
18. Untergasser A, Zedler U, Langenkamp A, Hosel M, Quasdorff M, et al. (2006) Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 43: 539-547.
19. Vincent IE, Balmelli C, Meehan B, Allan G, Summerfield A, et al. (2007) Silencing of natural interferon producing cell activation by porcine circovirus type 2 DNA. Immunology 120: 47-56.
20. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, et al. (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
21. Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, et al. (1998) Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A 95: 12631-12636.
22. Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, et al. (2007) TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 178: 3186-3197.
23. Fathallah I, Parroche P, Gruffat H, Zannetti C, Johansson H, et al. (2010) EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9. J Immunol.
24. Zhou J, Huang Y, Tian D, Xu D, Chen M, et al. (2009) Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. J Huazhong Univ Sci Technolog Med Sci 29: 313-317.
25. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, et al. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
26. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
27. Wu J, Meng Z, Jiang M, Pei R, Trippler M, et al. (2009) Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49: 1132-1140.
28. Wang H, Ryu WS, (2010) Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 6: e1000986.
29. Wei C, Ni C, Song T, Liu Y, Yang X, et al. (2010) The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol 185: 1158-1168.
30. Liew FY, Xu D, Brint EK, O'Neill LA, (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5: 446-458.
31. Schmitt S, Glebe D, Alving K, Tolle TK, Linder M, et al. (1999) Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus. J Biol Chem 274: 11945-11957.
32. Seeds RE, Gordon S, Miller JL, (2006) Receptors and ligands involved in viral induction of type I interferon production by plasmacytoid dendritic cells. Immunobiology 211: 525-535.
33. Cao W, Liu YJ, (2007) Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 19: 24-30.
34. Abe T, Hemmi H, Miyamoto H, Moriishi K, Tamura S, et al. (2005) Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 79: 2847-2858.
35. Klinman DM, Zeuner R, Yamada H, Gursel M, Currie D, et al. (2003) Regulation of CpG-induced immune activation by suppressive oligodeoxynucleotides. Ann N Y Acad Sci 1002: 112-123.
36. Krieg AM, (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
37. Shiina M, Rehermann B, (2007) Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology.
38. Martinelli E, Cicala C, Van Ryk D, Goode DJ, Macleod K, et al. (2007) HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 104: 3396-3401.
39. Xie Q, Shen HC, Jia NN, Wang H, Lin LY, et al. (2009) Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect 11: 515-523.
40. Aoyama T, Paik YH, Seki E, (2010) Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract.
41. Sells MA, Zelent AZ, Shvartsman M, Acs G, (1988) Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 62: 2836-2844.
42. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
43. Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, et al. (2007) Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 79: 1075-1081.
44. Ottone S, Nguyen X, Bazin J, Berard C, Jimenez S, et al. (2007) Expression of hepatitis B surface antigen major subtypes in Pichia pastoris and purification for in vitro diagnosis. Protein Expr Purif 56: 177-188.
45. Gherardi A, Peyrol S, Sarciron ME, (2005) Toxoplasma gondii: localization of purine nucleoside phosphorylase activity in vitro and in vivo by electron microscopy. Med Mol Morphol 38: 251-255.